SCHEMBL25387357

SCHEMBL25387357

Nc1nc2ccc(-c3cn(Cc4ccc(-c5nnc(C(F)F)o5)cc4)cn3)cc2s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 5/20 0.42
▸ PI4KA P42356 12/20 0.41
▸ PI4KB Q9UBF8 12/20 0.41
▸ PIK3CD O00329 11/20 0.41
▸ PIK3CG P48736 11/20 0.41
▸ PIK3CA P42336 11/20 0.41
▸ PIK3CB P42338 8/20 0.41
▸ PIP5K1C O60331 3/20 0.39
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ STAT1 P42224 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30424712 1.00 HDAC6 (0.42) HDAC6PI4KAPI4KBPIK3CDPIK3CG
SCHEMBL25213664 0.94 HDAC6 (0.44) HDAC6PIK3CDPIK3CGPIK3CAPIK3CB
SCHEMBL25213667 0.89 PIK3CA (0.45) HDAC6PI4KAPI4KBPIK3CDPIK3CG
SCHEMBL25389027 0.88 PI4KA (0.39) HDAC6PI4KAPI4KBPIK3CDPIK3CG
SCHEMBL30425066 0.86 HDAC6 (0.50) HDAC6PI4KAPI4KBPIK3CDPIK3CG
SCHEMBL25216541 0.86 HDAC6 (0.50) HDAC6PI4KAPI4KBPIK3CDPIK3CG
SCHEMBL30424980 0.82 HDAC6 (0.46) HDAC6PIK3CDPIK3CGPIK3CAPIK3CB
SCHEMBL25385354 0.82 HDAC6 (0.46) HDAC6PIK3CDPIK3CGPIK3CAPIK3CB
SCHEMBL25214466 0.82 HDAC6 (0.45) HDAC6PI4KAPI4KBPIK3CDPIK3CG
SCHEMBL25240955 0.82 PIK3CA (0.64) HDAC6PI4KAPI4KBPIK3CDPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286970-A1 NOVEL OXADIAZOLE-BASED SELECTIVE HDAC6 INHIBITORS ITALFARMACO SPA (IT) 2023-09-14 — — US claimed
US-20230286970-A1 NOVEL OXADIAZOLE-BASED SELECTIVE HDAC6 INHIBITORS ITALFARMACO SPA (IT) 2023-09-14 — — US disclosed
US-20230286970-A1 NOVEL OXADIAZOLE-BASED SELECTIVE HDAC6 INHIBITORS ITALFARMACO SPA (IT) 2023-09-14 — — US disclosed
US-20230286970-A1 NOVEL OXADIAZOLE-BASED SELECTIVE HDAC6 INHIBITORS ITALFARMACO SPA (IT) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286970-A1 NOVEL OXADIAZOLE-BASED SELECTIVE HDAC6 INHIBITORS HDAC6, HDAC1, HDAC3 HDAC6 1/4885PI4KA 1295/4885PI4KB 1093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback